GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Guangzhou Wondfo Biotech Co Ltd (SZSE:300482) » Definitions » EV-to-EBITDA

Guangzhou Wondfo Biotech Co (SZSE:300482) EV-to-EBITDA : 19.68 (As of May. 25, 2024)


View and export this data going back to 2015. Start your Free Trial

What is Guangzhou Wondfo Biotech Co EV-to-EBITDA?

EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Guangzhou Wondfo Biotech Co's enterprise value is ¥11,609 Mil. Guangzhou Wondfo Biotech Co's EBITDA for the trailing twelve months (TTM) ended in Mar. 2024 was ¥590 Mil. Therefore, Guangzhou Wondfo Biotech Co's EV-to-EBITDA for today is 19.68.

The historical rank and industry rank for Guangzhou Wondfo Biotech Co's EV-to-EBITDA or its related term are showing as below:

SZSE:300482' s EV-to-EBITDA Range Over the Past 10 Years
Min: 4.27   Med: 33.66   Max: 103.21
Current: 19.98

During the past 13 years, the highest EV-to-EBITDA of Guangzhou Wondfo Biotech Co was 103.21. The lowest was 4.27. And the median was 33.66.

SZSE:300482's EV-to-EBITDA is ranked worse than
61.07% of 488 companies
in the Medical Devices & Instruments industry
Industry Median: 16.205 vs SZSE:300482: 19.98

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2024-05-25), Guangzhou Wondfo Biotech Co's stock price is ¥27.91. Guangzhou Wondfo Biotech Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2024 was ¥1.130. Therefore, Guangzhou Wondfo Biotech Co's PE Ratio for today is 24.70.

The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio.


Guangzhou Wondfo Biotech Co EV-to-EBITDA Historical Data

The historical data trend for Guangzhou Wondfo Biotech Co's EV-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Guangzhou Wondfo Biotech Co EV-to-EBITDA Chart

Guangzhou Wondfo Biotech Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-EBITDA
Get a 7-Day Free Trial Premium Member Only Premium Member Only 27.75 33.81 18.30 7.82 14.80

Guangzhou Wondfo Biotech Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
EV-to-EBITDA Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 21.65 25.32 23.64 14.80 17.20

Competitive Comparison of Guangzhou Wondfo Biotech Co's EV-to-EBITDA

For the Medical Devices subindustry, Guangzhou Wondfo Biotech Co's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Guangzhou Wondfo Biotech Co's EV-to-EBITDA Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Guangzhou Wondfo Biotech Co's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Guangzhou Wondfo Biotech Co's EV-to-EBITDA falls into.



Guangzhou Wondfo Biotech Co EV-to-EBITDA Calculation

Guangzhou Wondfo Biotech Co's EV-to-EBITDA for today is calculated as:

EV-to-EBITDA=Enterprise Value (Today)/EBITDA (TTM)
=11609.085/589.959
=19.68

Guangzhou Wondfo Biotech Co's current Enterprise Value is ¥11,609 Mil.
Guangzhou Wondfo Biotech Co's EBITDA for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥590 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Guangzhou Wondfo Biotech Co  (SZSE:300482) EV-to-EBITDA Explanation

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

Guangzhou Wondfo Biotech Co's PE Ratio for today is calculated as:

PE Ratio=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=27.91/1.130
=24.70

Guangzhou Wondfo Biotech Co's share price for today is ¥27.91.
Guangzhou Wondfo Biotech Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥1.130.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio.

Please read Which price ratio outperforms the enterprise multiple?


Guangzhou Wondfo Biotech Co EV-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Guangzhou Wondfo Biotech Co's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


Guangzhou Wondfo Biotech Co (SZSE:300482) Business Description

Traded in Other Exchanges
N/A
Address
No. 8, Lizhishan Road, Science City, Luogang District, Guangdong, Guangzhou, CHN, 510641
Guangzhou Wondfo Biotech Co Ltd manufactures medical diagnostic tests. Its products include immunodiagnostic rapid test kits, including fertility, which include pregnancy HCG, ovulation LH, and others. The company's products are used in a clinical test, field test, and personal health management, among others.
Executives
He Xiao Wei Director
Kang Ke Ren Executives
Yu Fang Xia Executives
Li Wen Mei Directors, executives
Wang Ji Hua Director
Peng Zhong Xiong Executives
Zhao Ya Ping Executives
Luo Hong Supervisors
Zhou Yong Supervisors

Guangzhou Wondfo Biotech Co (SZSE:300482) Headlines

No Headlines